Generic

Dexlansoprazole is the active ingredient in DDR 30, a proton pump inhibitor (PPI) designed to reduce stomach acid production.

Description

DDR 30, developed by ACME Laboratories Ltd., is a sustained-release capsule of dexlansoprazole. This dual delayed-release formulation delivers prolonged relief for conditions related to excessive stomach acid, like GERD and erosive esophagitis.

Benefits

DDR 30 effectively reduces symptoms like heartburn and promotes the healing of erosive esophagitis. It maintains the healing process for up to 6 months, providing a long-term solution for acid reflux and GERD-related discomfort.

Ingredients

Each capsule contains 30 mg of dexlansoprazole, with a unique dual delayed-release system that ensures two peak plasma concentrations for extended relief.

Uses and Doses

• Healing of erosive esophagitis: 60 mg once daily for up to 8 weeks.
• Maintenance of healed esophagitis: 30 mg once daily for up to 6 months.
• Symptomatic non-erosive GERD: 30 mg once daily for 4 weeks.

Side Effects

Common side effects include nausea, diarrhea, abdominal pain, flatulence, and vomiting. If side effects persist or worsen, consult your healthcare provider.

How to Use

Take DDR 30 as prescribed, once daily without regard to food. Capsules should be swallowed whole, though they can be opened and sprinkled on food if necessary. Do not chew the granules.

Pregnancy & Lactation

DDR 30 is classified as Pregnancy Category B, meaning no well-controlled studies in pregnant women exist. Consult a doctor before using this medication while pregnant or breastfeeding.

Precautions and Warnings

Use with caution in individuals with liver impairment or a history of bone fractures. Long-term use may increase the risk of osteoporosis; supplementing with calcium and vitamin D is recommended.

Safety Information

Avoid using DDR 30 if allergic to any of its components. Report any unusual symptoms, like persistent diarrhea or fever, to your doctor. Do not double doses if a dose is missed.

Indications

DDR 30 is indicated for the treatment and maintenance of erosive esophagitis, symptomatic GERD, and heartburn associated with non-erosive GERD.

Pharmacology

Dexlansoprazole, the active ingredient in DDR 30, inhibits gastric acid production by blocking the proton pump in stomach parietal cells, resulting in reduced acid secretion.

Therapeutic Class

DDR 30 belongs to the proton pump inhibitor (PPI) class of medications.

Storage Conditions

Store below 30°C in a dry place, away from light. Keep out of reach of children.

3 FAQ

1. What is DDR 30 used for?
   DDR 30 treats and manages GERD, erosive esophagitis, and heartburn.
2. Can DDR 30 be taken with food?
   Yes, it can be taken without regard to food but should be swallowed whole.
3. Is DDR 30 safe for long-term use?
   Yes, but prolonged use may require monitoring for bone health and magnesium levels.

Disclaimer

DDR 30 is a prescription medication. Always consult a healthcare provider before starting or adjusting doses.

Keywords: DDR 30, dexlansoprazole, acid reflux, GERD, proton pump inhibitor, PPI, ACME Laboratories, heartburn relief, erosive esophagitis, dual delayed release, stomach acid, gastroesophageal reflux, GERD treatment, acid reduction, digestive health, capsule form, therapeutic class, dexlansoprazole 30 mg, ACME DDR 30, acid suppressant